Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol

by Rachel Dunn, Anita Mansouri, Naomi McGregor, Sam Dobbie, Jane Holmes, Linda Collins
Published 2021-01-01